Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449299) titled 'Rct Assessing Pregnancy - Piroxicam for Ec With Levonorgestrel' on Feb. 26.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: University of Utah
Condition:
Emergency Contraception
Contraception
COX-2 Inhibitor
Intervention:
Drug: Levonorgestrel 1.5 mg and Piroxicam 40 mg
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: March 2027
Target Sample Size: 1458
To know more, visit https://clinicaltria...